In last trading session, ABVC BioPharma Inc (NASDAQ:ABVC) saw 0.81 million shares changing hands with its beta currently measuring 0.31. Company’s recent per share price level of $2.59 trading at $0.4 or 18.26% at ring of the bell on the day assigns it a market valuation of $43.98M. That closing price of ABVC’s stock is at a premium of 11.58% from its 52-week high price of $2.29 and is indicating a premium of 84.56% from its 52-week low price of $0.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 415.76K if we extend that period to 3-months.

For ABVC BioPharma Inc (ABVC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

ABVC BioPharma Inc (NASDAQ:ABVC) trade information

Upright in the green during last session for gaining 18.26%, in the last five days ABVC remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $2.59 price level, adding 0.38% to its value on the day. ABVC BioPharma Inc’s shares saw a change of 247.98% in year-to-date performance and have moved 40.76% in past 5-day. ABVC BioPharma Inc (NASDAQ:ABVC) showed a performance of 89.05% in past 30-days. Number of shares sold short was 0.51 million shares which calculate 1.48 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 27.39% during past 5 years.

ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders

Insiders are in possession of 16.47% of company’s total shares while institution are holding 2.28 percent of that, with stock having share float percentage of 2.73%. Investors also watch the number of corporate investors in a company very closely, which is 2.28% institutions for ABVC BioPharma Inc that are currently holding shares of the company.